Eyepoint Pharmaceuticals, Inc.
EYPT
Revenue
24.45M
▲13.93M▲132.35%
6 Months ChangeAssets
362.56M
▼-55.90M▼-13.36%
3 Months ChangeLiabilities
64.17M
▼-17.80M▼-21.71%
3 Months ChangeFree Cash Flow
-53.40M
▼-21.03M▼-64.98%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001193125-24-248694
2024-10-28
Form 8-K
ID: 0000950170-24-117568
2024-10-24
Form 8-K
ID: 0000950170-24-116847
2024-09-04
Form 8-K
ID: 0000950170-24-103097
2024-08-08
Form 10-Q
ID: 0000950170-24-093853
2024-08-07
Form 8-K
ID: 0000950170-24-092262
2024-06-26
Form 8-K
ID: 0000950170-24-077636
2024-06-21
Form 8-K
ID: 0000950170-24-075872
2024-05-28
Form 8-K
ID: 0000950170-24-064879
2024-05-09
Form 10-Q
ID: 0000950170-24-056380